Important pharmacogenomic aspects in the management of HIV/AIDS
In managing HIV/AIDS with highly active antiretroviral agents, the historical therapeutic aim remains to maintain the plasma concentrations at a level above the half maximal inhibitory concentration (IC50) required for 50% inhibition in viral replication. Concentration dependent toxicity is often ob...
Saved in:
| Main Authors: | A. Marais, E. Osuch, V. Steenkamp, L. Ledwaba |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2019-03-01
|
| Series: | South African Family Practice |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/5047 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomics
by: M S Shivashankara
Published: (2020-01-01) -
Pharmacogenomics & its Application in Ophthalmology
by: Surabhi Gupta, et al.
Published: (2015-07-01) -
The pharmacological management of depression – Update 2017
by: Elzbieta Osuch, et al.
Published: (2017-03-01) -
Ethical Considerations in Carbamazepine Pharmacogenomics Testing
by: Madeline Yuzwa, et al.
Published: (2025-08-01) -
HIV/AIDS: management and stigma
by: Kerry Frizelle
Published: (2009-01-01)